Cleaning procedures are difficult for the Israeli cannabis industry, as companies have to pass their products through radiation in order to kill bacteria. However, Kanashur, a new cannabis company based in Israel has managed to breed its first batch of cannabis indoors. That means that the company can bypass all the cleaning procedures and reassure customers that no radiation was used.
The new Israeli cannabis company, Kanashur, announced on Monday, April 13th, that it has successfully undergone residue testing for its cannabis, for the first time, without passing the plants through radiation at the Sorek Institute, like all other cannabis products in Israel are forced to pass.
As Israeli producers and growers know, cannabis-based products must be treated with radiation for the purpose of disinfecting and killing bacteria, due to the Health Ministry’s new regulations on microbial cleaning and pesticide cleaning in medical cannabis.
Treating with radiation is mandatory even though it has not been scientifically proven to date that gamma or beta irradiation causes some cannabis or cannabinoid damage, except perhaps some traumatic injury. It is also not possible to state that there is no such damage caused – simply because this topic has not been investigated thoroughly.
If you want to know more about how the cannabis industry is developing in Israel, how radiation cleans cannabis from bacteria, and to find out the latest hemp news, download the Hemp.im mobile application.
A big achievement for Israel’s cannabis industry
Kanashur cannabis company managed to be the first in Israel to market cannabis that has not been treated with radiation, thanks to its indoor breeding facility. This week, the company received the IMC-GAP standard which allows it to grow cannabis under controlled conditions and not in greenhouses as the majority of other companies are growing cannabis plants.
“The lab results were received for our first growth cycle confirming that it is not necessary to treat it with radiation for disinfection and killing bacteria, in order to meet the quality requirements necessary,” the company said.
“The decision to allow the company not use radiation is due to the fact that Kanashur’s indoor growing facility provides optimal conditions for growth, including optimal temperature, humidity, light, air, water quality control, and compliance with both Israel and Europe quality standards.”
Indeed, from a study conducted last year, it was found that in Canada, for example, companies were forced to treat cannabis with radiation, with the exception of companies that grow it indoors – a method that allows them to maintain clean and sterile growing conditions as required by the standard.
Cannabis patients should not worry more about radiation
The news of the use of radiation to clean medical cannabis has been worrying patients for a long time. Nevertheless, the Ministry of Health does not require manufacturers to label the products with the radioactive symbol as is required in food products.
Ran Amir, CEO of Kanashur, said: “We are pleased to give two updates to our methods: the first one is, that after successfully completing the growth and validation of our first indoor batch, we have now received approval. Our indoor breeding and growing facility meet IMC-GAP standard. In addition, the laboratory tests we performed in the cannabis inflorescence revealed that they are not required to be treated with radiation for bacterial and microorganism killing. ”
He added: “We hope that this will be the case in all the company’s cannabis growth cycles. Complying with the IMC-GAP standard is the final step towards obtaining a final license for commercial growth. The final license will allow the company to commence commercial sales of these new indoor cannabis products, originated from the indoor breeding, growing and processing at our manufacturing facility. At the same time, Kanashur began commercial production at the brand’s production facility based on greenhouse-derived inflorescences.”
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in קנאביס, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.